Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaques
NCT07819643Phase 4Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Jan 2029
01
Overview
A Phase 4 trial of evolocumab, alirocumab in carotid artery stenosis, Carotid artery disease (CAD), cerebral atherosclerosis. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
evolocumabalirocumab
03
Conditions
carotid artery stenosisCarotid artery disease (CAD)cerebral atherosclerosis
Beyond the preview
Go deeper on NCT07819643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07819643.